tiprankstipranks
Trending News
More News >
Protalix Biotherapeutics (PLX)
:PLX
US Market

Protalix (PLX) Technical Analysis

Compare
789 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
3Neutral
4Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Protalix Biotherapeutics’s (PLX) Moving Averages Convergence Divergence (MACD) indicator is 0.03, suggesting Protalix Biotherapeutics is a Sell.
Protalix Biotherapeutics’s (PLX) 20-Day exponential moving average is 2.47, while Protalix Biotherapeutics’s (PLX) share price is $2.6, making it a Buy.
Protalix Biotherapeutics’s (PLX) 50-Day exponential moving average is 2.39, while Protalix Biotherapeutics’s (PLX) share price is $2.6, making it a Buy.

Protalix (PLX) Pivot Points

Apr 17, 2025, 03:59 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.51
2.55
2.58
2.62
2.66
2.70
2.73
Fibonacci
2.55
2.58
2.59
2.62
2.65
2.67
2.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Protalix (PLX) Moving Averages

Apr 17, 2025, 03:59 PM
Period
Simple
Exponential
MA5
2.51Buy
2.54Buy
MA10
2.45Buy
2.50Buy
MA20
2.49Buy
2.47Buy
MA50
2.45Buy
2.39Buy
MA100
2.22Buy
2.18Buy
MA200
1.65Buy
1.77Buy
Protalix Biotherapeutics’s (PLX) 10-Day exponential moving average is 2.50, while Protalix Biotherapeutics’s (PLX) share price is $2.6, making it a Buy.
Protalix Biotherapeutics’s (PLX) 100-Day exponential moving average is 2.18, while Protalix Biotherapeutics’s (PLX) share price is $2.6, making it a Buy.
Protalix Biotherapeutics’s (PLX) stock price is $2.6 and Protalix Biotherapeutics’s (PLX) 50-day simple moving average is 2.45, creating a Buy signal.
Protalix Biotherapeutics’s (PLX) stock price is $2.6 and Protalix Biotherapeutics’s (PLX) 100-day simple moving average is 2.22, creating a Buy signal.
Protalix Biotherapeutics’s (PLX) stock price is $2.6 and Protalix Biotherapeutics’s (PLX) 200-day simple moving average is 1.65, creating a Buy signal.

Protalix (PLX) Technical Indicators

Apr 17, 2025, 03:59 PM
Name
Value
Implied Action
RSI (14)
58.29
Neutral
STOCH (9,6)
92.77
Sell
STOCHRSI (14)
92.77
Sell
MACD (12,26)
0.03
Sell
ADX (14)
16.73
Buy
Williams %R
-11.76
Sell
CCI (14)
76.42
Neutral
ATR (14)
0.15
-
Ultimate Oscillator
61.34
Neutral
ROC
0.78
Buy
Protalix Biotherapeutics’s (PLX) Relative Strength Index (RSI) is 58.29, creating a Neutral signal.
Protalix Biotherapeutics’s (PLX) Trend Strength Indicator (ADX) is 16.73, creating a Buy signal.
Protalix Biotherapeutics’s (PLX) Commodity Channel Index (CCI) is 76.42, creating a Neutral signal.
Protalix Biotherapeutics’s (PLX) Price Rate of Change (ROC) is 0.78, creating a Buy signal.

FAQ

Is PLX a Buy, Hold, or Sell?
Based on PLX’s technical indicators, PLX is a Buy.
    What is PLX’s RSI (14)?
    PLX’s RSI (14) is 58.29, which suggests PLX is a Neutral.
      What is PLX’s MACD?
      PLX’s MACD is 0.03, which suggests PLX is a Sell.
        What is PLX’s 5-day moving average?
        PLX’s 5-day moving average is 2.51, which suggests PLX is a Buy.
          What is PLX’s 20-day moving average?
          PLX 20-day moving average is 2.49, which suggests PLX is a Buy.
            What is PLX’s 50-day moving average?
            PLX’s 50-day moving average is 2.45, which suggests PLX is a Buy.
              What is PLX’s 200-day moving average?
              PLX’s 200-day moving average is 1.65, which suggests PLX is a Buy.
                What is PLX’s Williams % R (14)?
                PLX’s Williams % R (14) is -11.76, which suggests PLX is a Sell.
                  What is PLX’s CCI (14)?
                  PLX’s CCI (14) is 76.42, which suggests PLX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis